Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-β through Smad and MAPK-mediated signalling

Molecular Human Reproduction

Volumn 11, Issue 7, 2005, Pages 489-494

  Levens, Eric ^a   Luo, Xiaoping ^a   Ding, Li ^a   Williams, R Stan ^a   Chegini, Nasser ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Fibromodulin; GnRH; Leiomyoma; MAPK; Myometrium; Smad; TGF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; FIBROMODULIN; GONADORELIN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANALYSIS OF VARIANCE; ARTERY WALL; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; GENE REPRESSION; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LEIOMYOMA; MENSTRUAL CYCLE; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VALIDATION PROCESS; WESTERN BLOTTING;

EXTRACELLULAR MATRIX PROTEINS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEIOMYOMA; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MYOMETRIUM; PROTEOGLYCANS; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UTERINE NEOPLASMS;

EID: 24344447877     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah187     Document Type: Article

References (56)

1. Ameye L, Aria D, Jepsen K, Oldberg A, Xu T and Young MF (2002) Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J 16,673-680.
2. Antonsson P, Hinegård D and Oldberg Å (1991) Posttranslational modifications of fibromodulin. J Biol Chem 266,16859-16861.
3. Arici A and Sozen I (2000) Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril 73,1006-1011.
4. Bartold PM and Narayanan AS (1998) Proteoglycans. In Bartold PM and Narayanan AS (eds), Biology of Periodontal Connective Tissues. Quintessence Press, Chicago, pp. 121-147.
5. Berto AG, Sampajo LO, Franco CR, Cesar RM Jr and Michelacci YM (2003) A comparative analysis of structure and spatial distribution of decorin in human leiomyoma and normal myometrium. Biochim Biophys Acta 1619,98-112.
6. Blochberger TC, Vergnes JP, Hempel J and Hassell JR (1992) cDNA to chick lumican (corneal keratan sulfate proteoglycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. J Biol Chem 267,347-352.
7. Burton-Wurster N, Liu W, Matthews GL, Lust G, Roughley PJ, Glant TT and Cs-Szabo G (2003) TGF beta 1 and biglycan, decorin, and fibromodulin metabolism in canine cartilage. Osteoarthritis Cartilage 11, 167-176.
8. Chakravarti S (2002) Functions of lumican and fibromodulin: Lessons from knockout mice. Glycoconj J 19,287-293.
9. Chegini N, Rong H, Dou Q, Kipersztok S and Williams RS (1996) Gonadotropin releasing hormone (GnRH) and GnRH receptor gene expression in human myometrial and leiomyomta and the direct action of GnRH analogs on myometrial smooth muscle cells interaction with ovarian steroids in vitro. J Clin Endocrinol Metab 81,3215-3221.
10. Chegini N, Tang XM and Ma C (1999) Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab 84,4138-4143.
11. Chegini N, Ma C, Tang XM and Williams RS (2002) Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Mol Hum Reprod 8,1071-1078.
12. Chegini N, Verala J, Luo X, Xu J and Williams RS (2003a) Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig 10, 161-171.
13. Chegini N, Luo X, Ding L and Ripley D (2003b) The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol 209,9-16.
14. Cheng CK and Leung PC (2005) Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 26,283-306.
15. Ding L, Xu J, Luo X and Chegini N (2004) Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab 89,5549-5557.
16. Dou Q, Tarnuzzer RW, Williams RS, Schultz GS and Chegini N (1997) Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: A mechanism for gonadotrophin releasing hormone agonist-induced tumour regression. Mol Hum Reprod 3,1005-1014.
17. Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS and Chegini N (1996) Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 81,3222-3230.
18. Everest HM, Hislop JN, Harding T, Uney JB, Flynn A, Millar RP and McArdle CA (2001) Signaling and antiproliferative effects mediated by GnRH receptors after expression in breast cancer cells using recombinant adenovirus. Endocrinology 142,4663-4672.
19. Ezura Y, Chakravarti S, Oldberg A, Chervoneva I and Birk DE (2000) Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol 151,779-788.
20. Font B, Eichenberger D, Goldschmidt D, Boutillon MM and Hulmes DJ (1998) Structural requirements for fibromodulin binding to collagen and the control of type I collagen fibrillogenesis - critical roles for disulphide bonding and the C-terminal region. Eur J Biochem 254,580-587.
21. Fukushima D, Butzow R, Hidlebrand A and Ruoslahti E (1993) Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans. J Biol Chem 268,22710-22715.
22. Gori F, Schipani E and Demay MB (2001) Fibromodulin is expressed by both chondrocytes and osteoblasts during fetal bone development. J Cell Biochem 82,46-57.
23. Grundker C, Volker P and Emons G (2001) Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein a (I) -mediated activation of phosphotyrosine phosphatase. Endocrinology 142,2369-2380.
24. Heathfield TF, Onnerfjord P, Dahlberg L and Heinegard D (2004) Cleavage of fibromodulin in cartilage explants involves removal of the N-terminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13. J Biol Chem 279,6286-6295.
25. Hedbom E and Heinegård D (1993) Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem 268,27307-27312.
26. Hedlund H, Mengarelli-Widholm S, Heinegård D, Reinholt FP and Svensson O (1994) Fibromodulin distribution and association with collagen. Matrix Biol 14,227-232.
27. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA and Ruoslahti E (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302,527-534.
28. Kinsella MG, Bressler SL and Wight TN (2004) The regulated synthesis of versican, decorin, and biglycan: Extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 14,203-234.
29. Lee BS, Margolin SB and Nowak RA (1998) Pirfenidone: A novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production. J Clin Endocrinol Metab 83,219-223.
30. Lee BS and Nowak RA (2001) Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF-β3) and altered responses to the antiproliferative effects of TGFβ. J Clin Endocrinol Metab 86,913-920.
31. Leppert PC, Baginski T, Prupas C, Catherino WH, Pletcher S and Segars JH (2004) Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril 82 (Suppl. 3),1182-1187.
32. Luo X, Ding L, Xu J, Williams RS and Chegini N (2005a) Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy. Endocrinology 146,1074-1096.
33. Luo X, Ding L, Xu J and Chegini N (2005b) Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-{beta}. Endocrinology 146,1097-1118.
34. Luo X, Ding L and Chegini N (2005c) Expression of CCNs, fibulin and S100A4 in leiomyoma and myometrium: Their inverse correlation with TGF-b1/TGF-b3 and regulation by TGF-b and GnRHa in leiomyoma and myometrial smooth muscle cells. J Soc Gynecol Investig 12,94A.
35. Melrose J, Ghosh P and Taylor TK (2001) A comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) proteoglycans of the intervertebral disc. J Anat 198(Pt 1),3-15.
36. Neame PJ, Sommarin Y, Boynton RE and Heinegård D (1994) The structure of a 38-kD leucine-rich protein (chondroadherin) isolated from bovine cartilage. J Biol Chem 269,21547-21554.
37. Noonan DM and Hassell JR (1993) Perlecan. The large low-density proteoglycan of basement membranes: Structure and variant forms. Kidney Int 43,53-60.
38. Palmer SS, Haynes-Johnson D, Diehl T and Nowak RA (1998) Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium. J Soc Gynecol Investig 5,203-209.
39. Petri JB, Rott O, Wetzig T, Herrmann K and Haustein UF (1999) The small proteoglycan fibromodulin is expressed in mitotic, but not in postmitotic fibroblasts. Mol Cell Biol Res Commun 1,59-65.
40. Raga F, Casan EM, Wen Y, Huang HY, Bonilla-Musoles F and Polan ML (1999) Independent regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 in human endometrial stromal cells by gonadotropin-releasing hormone: Implications in early human implantation. J Clin Endocrinol Metab 84,636-642.
41. San Martin S, Soto-Suazo M, De Oliveira SF, Aplin JD, Abrahamsohn P and Zorn TM (2003) Small leucine-rich proteoglycans (SLRPs) in uterine tissues during pregnancy in mice. Reproduction 125,585-595.
42. Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, Lorenz HP, Hedrick MH, Mackool RJ, Plaas A, Kim SJ et al. (2000) Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. Am J Pathol 157,423-433.
43. Stewart EA, Friedman AJ, Peck K and Nowak RA (1994) Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab 79,900-906.
44. Stewart EA, Rhoades AR and Nowak RA (1998) Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid. J Soc Gynecol Investig 5,44-47.
45. Strom A, Ahlqvist E, Franzen A, Heinegard D and Hultgardh-Nilsson A (2004) Extracellular matrix components in atherosclerotic arteries of Apo E/LDL receptor deficient mice: An immunohistochemical study. Histol Histopathol 19,337-347.
46. Svensson L, Aszodi A, Reinholt FP, Fassler R, Heinegard D and Oldberg A (1999) Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 274,9636-9647.
47. Tang XM, Dou Q, Zhao Y, McLean F, Davis J and Chegini N (1997) The expression of transforming growth factor-beta s and TGF-b receptor mRNA and protein and the effect of TGF-b on human myometrial smooth muscle cells in vitro. Mol Hum Reprod 3,233-240.
48. Tsibris JC, Segars J, Coppola D, Mane S, Wilbanks GD, O'Brien WF and Spellacy WN (2002) Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 78,114-121.
49. Venkatesan N, Ebihara T, Roughley PJ and Ludwig MS (2000) Alterations in large and small proteoglycans in bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 161,2066-2073.
50. Wang H, Mahadevappa M, Yamamoto K, Wen Y, Chen B, Warrington JA and Polan ML (2003a) Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertil Steril 80,266-276.
51. Wang JF, Olson ME, Ball DK, Brigstock DR and Hart DA (2003b) Recombinant connective tissue growth factor modulates porcine skin fibroblast gene expression. Wound Repair Regen 11,220-229.
52. Westergren-Thorsson G, Norman M, Bjornsson S, Endresen U, Stjernholm Y, Ekman G and Malmstrom A (1998) Differential expressions of mRNA for proteoglycans, collagens and transforming growth factor-beta in the human cervix during pregnancy and involution. Biochim Biophys Acta 1406,203-213.
53. Weston G, Trajstman AC, Gargett CE, Manuelpillai U, Vollenhoven BJ and Rogers PA (2003) Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol Hum Reprod 9,541-549.
54. Xu J, Luo X and Chegini N (2003) Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog. J Clin Endocrinol Metab 88,1350-1361.
55. Yanagishita M (1993) Function of proteoglycans in the extracellular matrix. Acta Pathol Jpn 43,283-293.
56. Yu L, Border WA, Huang Y and Noble NA (2003) TGF-β isoforms in renal fibrogenesis. Kidney Int 64,844-856.